Los Angeles Capital Management’s Core Laboratories CLB Stock Holding History

Los Angeles Capital Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$369K	Buy	22,001 +11,815	+116%	+$211K	﹤0.01%	966
2025 Q4	$163K	Hold	10,186	–	–	﹤0.01%	1299
2025 Q3	$126K	Buy	+10,186	New	+$119K	﹤0.01%	1312
2015 Q1	–	Sell	-2,000	Closed	-$241K	–	1211
2014 Q4	$241K	Buy	+2,000	New	+$263K	﹤0.01%	1027
2014 Q3	–	Sell	-28,552	Closed	-$4.77M	–	1081
2014 Q2	$4.77M	Buy	28,552 +4,444	+18%	+$791K	0.05%	352
2014 Q1	$4.78M	Buy	+24,108	New	+$4.55M	0.05%	349

Other funds holding CLB

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Los Angeles Capital Management's CLB Position: Q1 2026 in Review

Los Angeles Capital Management increased its Core Laboratories (CLB) stake by 116% in Q1 2026, buying an estimated $211K and bringing the position to 22,001 shares worth $369K. The position accounts for ﹤0.01% of the portfolio, ranked #966.

Los Angeles Capital Management first reported a position in CLB in Q1 2014 and has held it in 6 quarters since. The position peaked at $4.78M in Q1 2014. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.

Los Angeles Capital Management held 22,001 shares of Core Laboratories worth $369K as of Q1 2026.
Los Angeles Capital Management bought 11,815 Core Laboratories shares in Q1 2026, an estimated $211K.
Core Laboratories made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #966 holding.
Los Angeles Capital Management first reported a position in Core Laboratories in Q1 2014 and has held it in 6 quarters since.
Los Angeles Capital Management's Core Laboratories position peaked at $4.78M in Q1 2014.
190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.